Sound Income Strategies’s Apellis Pharmaceuticals APLS Stock Holding History

Sound Income Strategies’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-621	Closed	-$25.1K	–	581
2026 Q1	$25.1K	Hold	621	–	–	﹤0.01%	1094
2025 Q4	$12.4K	Buy	+621	New	+$14.6K	﹤0.01%	1352

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sound Income Strategies's APLS Position: Q2 2026 in Review

Sound Income Strategies sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 621 shares — an estimated $25.1K sold.

Sound Income Strategies first reported a position in APLS in Q4 2025 and held it in 2 quarters. The position peaked at $25.1K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Sound Income Strategies reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Sound Income Strategies sold 621 Apellis Pharmaceuticals shares in Q2 2026, an estimated $25.1K.
Sound Income Strategies first reported a position in Apellis Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Sound Income Strategies's Apellis Pharmaceuticals position peaked at $25.1K in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.